{"id":"34aad0f5-15e0-46a5-abdb-454c1e0f32e0","kind":"news","code":"34aad0f5-15e0-46a5-abdb-454c1e0f32e0","name":"Shenxuan Technology completes equity financing","nameBasis":"translated-title","summary":"On 2026-08-11, according to Xiniu Data, Shenxuan Technology completed equity financing for an undisclosed amount. Investors were Shanghai Lanchixinhao Venture Capital Partnership (Limited Partnership), Muhuashuiqing (Shanghai) Venture Capital Partnership (Limited Partnership), Salus Medix Limited. The company is an AI-driven innovative macromolecular drug discovery platform.","description":"","country":null,"category":null,"originalName":"深旋科技完成股权投资融资","eventDate":"2026-08-11T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T16:32:29.539Z","englishUpdatedAt":"2026-10-20T18:26:58.797Z","reviewedAt":"2026-10-20T18:26:58.797Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"6f8c98d05b67e741fa64b03a6c0534621d27c90689a7949fa231904312683fc5","companyId":"e279072a-d572-4324-a606-9a9b6958e5a2","foundedYear":null,"logoUrl":null,"originalText":"2026年8月11日，据烯牛数据报道，深旋科技完成股权投资融资，金额未披露。投资方为上海蓝驰新皓创业投资合伙企业（有限合伙），木华水清（上海）创业投资合伙企业（有限合伙），Salus Medix Limited。该公司为AI驱动大分子创新药发现平台。","sources":[],"related":[{"id":"bc9991e5-ab7b-4798-941f-8ad012955dd4","kind":"institutions","code":"UB-I7225","name":"Salus Medix Limited","nameBasis":"original-brand","summary":"Salus Medix Limited, an investment firm.","description":"Salus Medix Limited, an investment firm.","country":null,"category":null,"originalName":"Salus Medix Limited","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T10:00:42.347Z","englishUpdatedAt":"2026-10-20T18:27:03.419Z","reviewedAt":"2026-10-20T18:27:03.419Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"04acc42412228adaee69697b0a168f59e5b7f8030789f1cad391b2c1d59a0ae8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/salus-medix-limited"},{"id":"e279072a-d572-4324-a606-9a9b6958e5a2","kind":"companies","code":"UB-C9949","name":"Shenxuan Technology","nameBasis":"transliterated","summary":"AI-driven innovative macromolecular drug discovery platform.","description":"AI-driven innovative macromolecular drug discovery platform.","country":"China","category":null,"originalName":"深旋科技","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:36.921Z","reviewedAt":"2026-10-20T18:26:36.921Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"0545ab012ec43b6add31ebdfe399052788f9d511815f32886ba9c5e8f7755a33","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C9949"}],"path":"/news/34aad0f5-15e0-46a5-abdb-454c1e0f32e0","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Shenxuan Technology","path":"/companies/UB-C9949"}},"canonical":"https://uniquebase.ai/news/34aad0f5-15e0-46a5-abdb-454c1e0f32e0"}